Schedule 13G ownership disclosure

ARENA PHARMACEUTICALS INC

Security class unavailable · CUSIP: 040047102

Event date: 2014-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
29,101,919
Percent of class
13.2200%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902219-15-000074
Form type
SC 13G/A
Filer
ARENA PHARMACEUTICALS INC
CIK
CIK 1080709
Filed
Feb 12, 2015
Reporting period
Dec 31, 2014
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub